Last reviewed · How we verify

NCT04256187

Pros and Cons of Botulinum Injection Treatment in Cerebral Palsy

Completed Last updated 20 January 2021
What this trial tests

trial testing Qualitative interview in Cerebral Palsy in 21 participants. Completed in 1 January 2021.

Timeline
1 November 2019
Primary endpoint
30 December 2020
1 January 2021

Quick facts

Lead sponsorMarmara University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment21
Start date1 November 2019
Primary completion30 December 2020
Estimated completion1 January 2021
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Marmara University

Who can join

Adults 18 to 65, any sex, with Cerebral Palsy or Botulinum Toxin. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to quantitatively record the opinions regarding the pros and cons of this treatment of the caregivers of children with cerebral palsy who had botulinum toxin applied in investigators' clinic.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Qualitative interview

Trials testing the same drug.

Other recruiting trials for Cerebral Palsy

Currently open trials in the same condition.

Other Marmara University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04256187.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing